Corsera Health
CompanyUnited States
Corsera Health develops 2 assets, the furthest in phase 1 (COR-1004). Mostly other acting on lipid and ceramide metabolism; based in the United States.
- 2
- Assets
- Furthest stage
- Phase 1
- 1
- Trial
- 1
- Signal
Pipeline
2Investigational agent co-administered with COR-2003 for cardiovascular risk factors
Phase 1, Other, Lipid and ceramide metabolism
Subcutaneous agent evaluated for blood pressure and LDL cholesterol reduction
Phase 1, Other, Lipid and ceramide metabolism
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Signals1
- Similar companies6